KKR nabs 6.7x return through full exit of Galenica

US buyout giant KKR has scored a 6.7-times return after selling its stake in Switzerland-listed pharmaceutical company Galenica. The full exit of the business comes nine years after KKR made its initial invest company, with the firm acquiring a stake in Galencia throughout the 2007 buyout of Alliance Boots. The shares were placed broadly among …